Amneal Pharmaceuticals (AMRX) Shares Outstanding (2017 - 2026)
Amneal Pharmaceuticals (AMRX) Shares Outstanding (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 43.50 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 31.59 Bn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.72 Bn | 320.11 Mn | 316.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316.02 Mn |
| Dec 31, 2025 | 313.37 Mn |
| Sep 30, 2025 | 314.17 Mn |
| Jun 30, 2025 | 313.74 Mn |
| Mar 31, 2025 | 311.05 Mn |
| Dec 31, 2024 | 308.98 Mn |
| Sep 30, 2024 | 309.65 Mn |
| Jun 30, 2024 | 309.12 Mn |
| Mar 31, 2024 | 307.28 Mn |
| Dec 31, 2023 | 176.14 Mn |
| Sep 30, 2023 | 154.22 Mn |
| Jun 30, 2023 | 153.74 Mn |
| Mar 31, 2023 | 152.11 Mn |
| Dec 31, 2022 | 150.94 Mn |
| Sep 30, 2022 | 151.39 Mn |
| Jun 30, 2022 | 150.99 Mn |
| Mar 31, 2022 | 149.89 Mn |
| Dec 31, 2021 | 148.92 Mn |
| Sep 30, 2021 | 149.29 Mn |
| Jun 30, 2021 | 149.00 Mn |